Synapse Peptides
GLP3-RTA
View COA (PDF)
Lot SPRETA001 · 99.85% purity · Tested 2026-07-02
Overview
Synthetic 39-amino-acid triple agonist of GLP-1R, GIPR, and GCGR. Investigational reference compound for studies of multi-receptor metabolic signalling.
Compound data
- Lot
- SPRETA001
- Purity
- 99.85%
- Assay method
- HPLC-MS
- Test date
- 2026-07-02
- Molecular weight
- 4731.4 g/mol
- Manufacture
- US
- Sequence
39-amino-acid peptide with C20 fatty-diacid modification (full sequence per supplier COA)
Description
Synthetic Reference Compound For Laboratory Research And Analytical Applications, Supporting Experimental And Investigative Studies In Controlled Research Environments. Strictly Intended For Laboratory Use Only. Not For Human Or Animal Use, Consumption, Or Therapeutic Use.
Research use
All products are supplied for laboratory and research use only and are not for human consumption, diagnostic, or therapeutic use.
Related products
-
LOT SP5AMQ001
Select options This product has multiple variants. The options may be chosen on the product page
-
LOT SPTIRZ001
Select options This product has multiple variants. The options may be chosen on the product page
-
LOT SPSEM001
Select options This product has multiple variants. The options may be chosen on the product page
-
LOT SPCAGR001
Select options This product has multiple variants. The options may be chosen on the product page
